These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7087041)

  • 21. Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
    Dou YN; Zheng J; Foltz WD; Weersink R; Chaudary N; Jaffray DA; Allen C
    J Control Release; 2014 Mar; 178():69-78. PubMed ID: 24440663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors.
    Koning GA; Eggermont AM; Lindner LH; ten Hagen TL
    Pharm Res; 2010 Aug; 27(8):1750-4. PubMed ID: 20424894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leakage and delivery of liposome-encapsulated methotrexate-gamma-aspartate in a chemically defined medium.
    Comiskey SJ; Heath TD
    Biochim Biophys Acta; 1990 May; 1024(2):307-17. PubMed ID: 2354182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
    Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
    Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A murine model for bladder cancer.
    Murphy GP; Sandberg AA; Pontes JE; Ochi H; Yoshida M; Williams PD
    Prog Clin Biol Res; 1984; 162A():177-200. PubMed ID: 6541340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate.
    Weinstein JN; Magin RL; Cysyk RL; Zaharko DS
    Cancer Res; 1980 May; 40(5):1388-95. PubMed ID: 6892792
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
    Soloway MS; Martino C; Hyatt C; Marrone JC
    Natl Cancer Inst Monogr; 1978 Dec; (49):293-300. PubMed ID: 748783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes.
    Zhu L; Huo Z; Wang L; Tong X; Xiao Y; Ni K
    Int J Pharm; 2009 Mar; 370(1-2):136-43. PubMed ID: 19114095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light/magnetic hyperthermia triggered drug released from multi-functional thermo-sensitive magnetoliposomes for precise cancer synergetic theranostics.
    Guo Y; Zhang Y; Ma J; Li Q; Li Y; Zhou X; Zhao D; Song H; Chen Q; Zhu X
    J Control Release; 2018 Feb; 272():145-158. PubMed ID: 28442407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection from carcinogen-induced murine bladder carcinoma by interferons and an oral interferon-inducing pyrimidinone, bropirimine.
    Borden EC; Sidky YA; Ertürk E; Wierenga W; Bryan GT
    Cancer Res; 1990 Feb; 50(4):1071-4. PubMed ID: 2297754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schedule dependency of the combination methotrexate-vinblastine against human urothelial cancer grown in nude mice.
    Kyriazis AP; Yagoda A; Kyriazis AA
    Anticancer Res; 1989; 9(6):1857-61. PubMed ID: 2627132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma.
    Haas GP; Klugo RC; Hetzel FW; Barton EE; Cerny JC
    J Urol; 1984 Oct; 132(4):828-33. PubMed ID: 6540817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cell proliferation with antibody-targeted liposomes containing methotrexate-gamma-dimyristoylphosphatidylethanolamine.
    Noé C; Hernandez-Borrell J; Kinsky SC; Matsuura E; Leserman L
    Biochim Biophys Acta; 1988 Dec; 946(2):253-60. PubMed ID: 3207742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposome-encapsulated methotrexate interactions with human chronic lymphocytic leukemia cells.
    Todd JA; Levine AM; Tökés ZA
    J Natl Cancer Inst; 1980 Apr; 64(4):715-9. PubMed ID: 6928985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect.
    Li Y; Lin J; Wu H; Chang Y; Yuan C; Liu C; Wang S; Hou Z; Dai L
    Mol Pharm; 2015 Mar; 12(3):769-82. PubMed ID: 25625539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of entrapment in liposomes on the in vivo distribution of [3H]methotrexate in a primate.
    Kimelberg HK; Tracy TF; Biddlecome SM; Bourke RS
    Cancer Res; 1976 Aug; 36(8):2949-57. PubMed ID: 819137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors.
    Chelvi TP; Jain SK; Ralhan R
    Oncol Res; 1995; 7(7-8):393-8. PubMed ID: 8747602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
    Derycke AS; Kamuhabwa A; Gijsens A; Roskams T; De Vos D; Kasran A; Huwyler J; Missiaen L; de Witte PA
    J Natl Cancer Inst; 2004 Nov; 96(21):1620-30. PubMed ID: 15523091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental and clinical studies on anal submucosal injection of methotrexate for bladder cancer].
    Yoshida T; Ogawa T; Fujinaga T; Kyoku I
    Hinyokika Kiyo; 1991 Aug; 37(8):857-61. PubMed ID: 1957728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity.
    O'Donnell MA; Luo Y; Hunter SE; Chen X; Hayes LL; Clinton SK
    J Urol; 2004 Mar; 171(3):1330-5. PubMed ID: 14767343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.